Catalyst Wire Dossier Catalyst Wire Dossier

GSP 301

· Glenmark Specialty S.A.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GSP 301, covering 2017-06-28 to 2018-08-15. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR) [Phase 3]

See pricing